policy
The Global Institute for Talented Education at KAIST has begun providing middle and high school students with in-depth online science education.
The institute receives applications until March 20, 2016. For details, please refer to the website: http://talented.kaist.ac.kr.
The program will run from March 21, 2016 to June 13, 2016.
Any middle and high school student can take courses on mathematics, science (physics, chemistry and biology), and information system (C language and Python computer language) based on their levels and needs. A total of 23 courses will be offered at the level of the first year of middle school to the second year of high school.
The online lecturers are drawn from science-magnet high schools nationwide. They will lead the classes to become more interactive with students, encouraging discussions and questions and answers.
KAIST students will also take part as tutors, helping the middle and high school students better understand the basic concept of the subjects they undertake and and to think creatively to solve problems.
About 500 top students will be chosen from the online course applicants to participate in a science camp hosted by KAIST during summer and winter vacations.
-
research Revolutionary 'scLENS' Unveiled to Decode Complex Single-Cell Genomic Data
Unlocking biological information from complex single-cell genomic data has just become easier and more precise, thanks to the innovative 'scLENS' tool developed by the Biomedical Mathematics Group within the IBS Center for Mathematical and Computational Sciences led by Chief Investigator Jae Kyoung Kim, who is also a professor at KAIST. This new finding represents a significant leap forward in the field of single-cell transcriptomics. Single-cell genomic analysis is an advanced technique that m
2024-05-09 -
research KAIST Develops Sodium Battery Capable of Rapid Charging in Just a Few Seconds
Sodium (Na), which is over 500 times more abundant than lithium (Li), has recently garnered significant attention for its potential in sodium-ion battery technologies. However, existing sodium-ion batteries face fundamental limitations, including lower power output, constrained storage properties, and longer charging times, necessitating the development of next-generation energy storage materials. On the 11th of April, KAIST (represented by President Kwang Hyung Lee) announced that a research t
2024-04-18 -
research KAIST introduces microbial food as a strategy food production of the future
The global food crisis is increasing due to rapid population growth and declining food productivity to climate change. Moreover, today's food production and supply system emit a huge amount of carbon dioxide, reaching 30% of the total amount emitted by humanity, aggravating climate change. Sustainable and nutritious microbial food is attracting attention as a key to overcoming this impasse. KAIST (President Kwang Hyung Lee) announced on April 12th that Research Professor Kyeong Rok Choi of th
2024-04-12 -
research KAIST researchers developed a novel ultra-low power memory for neuromorphic computing
A team of Korean researchers is making headlines by developing a new memory device that can be used to replace existing memory or used in implementing neuromorphic computing for next-generation artificial intelligence hardware for its low processing costs and its ultra-low power consumption. KAIST (President Kwang-Hyung Lee) announced on April 4th that Professor Shinhyun Choi's research team in the School of Electrical Engineering has developed a next-generation phase change memory* device fe
2024-04-04 -
research A KAIST-SNUH Team Devises a Way to Make Mathematical Predictions to find Metabolites Related to Somatic Mutations in Cancers
Cancer is characterized by abnormal metabolic processes different from those of normal cells. Therefore, cancer metabolism has been extensively studied to develop effective diagnosis and treatment strategies. Notable achievements of cancer metabolism studies include the discovery of oncometabolites* and the approval of anticancer drugs by the U.S. Food and Drug Administration (FDA) that target enzymes associated with oncometabolites. Approved anticancer drugs such as ‘Tibsovo (active ingre
2024-03-18